| 靶点: |
IC50: 0.047 µM (KIF18A motor); 0.224 µM (KIF19A motor); 17.73 µM (KIF18B motor) |
| 体内研究: |
AM-5308(25 mg/kg,腹腔注射,每日一次,共2天)在小鼠 OVCAR-3 异种移植模型中表现出抗肿瘤活性。 |
| 参考文献: |
1. Marc Noel PAYTON, et al. Kif18a inhibitors for treatment of neoplastic diseases. WO2021211549A1.2. Payton M, et al., Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers. Nat Cancer. 2024 Jan;5(1):66-84. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.888 ml |
9.44 ml |
18.88 ml |
| 5 mM |
0.378 ml |
1.888 ml |
3.776 ml |
| 10 mM |
0.189 ml |
0.944 ml |
1.888 ml |
| 50 mM |
0.038 ml |
0.189 ml |
0.378 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |